Rowlandmiller & Partners.Adv Portfolio Changes in Q2 2026

According to insider transaction data available on InsiderSet, Rowlandmiller & Partners.Adv made several notable changes to its portfolio holdings during the second quarter of 2026. The total portfolio value stood at $533,614,766 as of June 30th, reflecting adjustments across various sectors and individual stocks.

Sector Allocations

The investor's current sector allocation shows Technology leading with a significant 25.42%, followed by Financial Services at 14.05% and Healthcare at 13.07%. Other substantial allocations include Industrials (10.88%), Consumer Defensive (9.61%), Communication Services (8.91%), Consumer Cyclical (7.89%), Energy (3.22%), Utilities (2.06%) and Unknown (3.2%).

Purchases & Sales Overview

The filing indicates activity across multiple sectors, including Technology, Financial Services, Healthcare, and Communication Services. Notable purchases include additions to positions in the Vanguard Growth ETF (VUG) which saw a 50.0% increase in shares ($754k value), several small-cap tech/pharma companies like Gilead Sciences (GILD), Bio-Techne (TECH) and Intel (INTC) which also increased slightly, though the data shows conflicting allocations for Intel between top holdings and changed holdings.

Detailed Changes

The following table summarizes the key changes observed in Rowlandmiller & Partners.Adv's portfolio during Q2 2026:

• Technology Sector Reductions: Intel (INTC) experienced a significant reduction in holdings, with shares decreasing by 5.42% ($22M change) and allocation dropping to 4.07%. Similarly, large Technology stocks like Apple (AAPL) saw a slight decrease in portfolio weight (-0.36%) but substantial share reduction (-2963 shares).
• Financial Services Reductions: Western Union (WU) was sold significantly, with holdings down 15.53% ($439k change) and allocation falling to 0.08%. Large Financial Services positions like Truist (TFC) also decreased slightly (-1.43%) while others remained stable.
• Healthcare Reductions: Several Healthcare holdings saw reductions, including Gilead Sciences (GILD) which dropped by 0.84% (-$1M change) and Bio-Techne (TECH) decreased by 0.43%. However, the investor also added to positions in Eli Lilly (LLY), Gilead Sciences (GILD) and several small-cap pharma companies.
• New Positions & Increases: The investor initiated a position in the Vanguard Growth ETF (VUG) with substantial buying activity (+50.0% or +$754k). Other additions include Werner Enterprises (WERN) and several small-cap tech/pharma companies like Gilead Sciences (GILD), Bio-Techne (TECH) and Intel (INTC) which also increased slightly.
• No Activity: There is no disclosed activity for sectors like Consumer Staples, Materials, or Real Estate based on the provided data.

Technology Sector Focus Shifts

The Technology sector allocation decreased from its previous period weight of 30.49% to 25.42%, indicating a strategic shift away from large-cap tech stocks in this quarter's portfolio adjustments. While the investor maintained exposure through companies like Apple (AAPL), which still holds significant weight at 6.68%, there were notable reductions across other Technology holdings such as Intel (INTC) down to 4.07% and Microsoft (MSFT) slightly reduced from its previous period change.

Communication Services Gains & Losses

The Communication Services sector allocation saw a slight decrease to 8.91% ($47M total value) this quarter, down from the prior period's weight of 9.65%. Google (GOOG) experienced a small reduction (-0.34%) while significant buying occurred in Netflix (NFLX), adding 32.94% ($1.95M) to its position.

Conclusion

The portfolio adjustments by Rowlandmiller & Partners.Adv in Q2 2026 reflect a mix of strategic reductions and targeted additions across various sectors, including Technology, Financial Services, Healthcare, and Communication Services. The investor's focus appears to have shifted slightly away from large-cap Technology stocks while maintaining significant exposure elsewhere.